These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11958572)

  • 1. Increased bioactive TNF in human systemic lupus erythematosus: associations with cell death.
    Aringer M; Feierl E; Steiner G; Stummvoll GH; Höfler E; Steiner CW; Radda I; Smole JS; Graninger WB
    Lupus; 2002; 11(2):102-8. PubMed ID: 11958572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial construction of apoptotic pathway in PBMC obtained from active SLE patients and the significance of plasma TNF-alpha on this pathway.
    Pitidhammabhorn D; Kantachuvesiri S; Totemchokchyakarn K; Kitiyanant Y; Ubol S
    Clin Rheumatol; 2006 Sep; 25(5):705-14. PubMed ID: 16391890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis.
    Morita C; Horiuchi T; Tsukamoto H; Hatta N; Kikuchi Y; Arinobu Y; Otsuka T; Sawabe T; Harashima S; Nagasawa K; Niho Y
    Arthritis Rheum; 2001 Dec; 44(12):2819-27. PubMed ID: 11762942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N; Yamaguchi S; Yamaoka M; Okuyama M; Nakamura H; Tomoike H
    J Mol Cell Cardiol; 1998 Oct; 30(10):2003-12. PubMed ID: 9799654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li X; Liu L; Meng D; Wang D; Zhang J; Shi D; Liu H; Xu H; Lu L; Sun L
    Stem Cells Dev; 2012 Sep; 21(13):2387-94. PubMed ID: 22375903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM; Taher TE; Isenberg DA; Mageed RA
    Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus.
    Midgley A; McLaren Z; Moots RJ; Edwards SW; Beresford MW
    Arthritis Rheum; 2009 Aug; 60(8):2390-401. PubMed ID: 19644848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of TNF-alpha signaling pathway proteins in systemic lupus erythematosus.
    Zhu LJ; Landolt-Marticorena C; Li T; Yang X; Yu XQ; Gladman DD; Urowitz MB; Fortin PR; Wither JE
    J Rheumatol; 2010 Aug; 37(8):1658-66. PubMed ID: 20516030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients.
    Rathore VB; Advani SH; Nadkarni JJ
    Cancer Detect Prev; 1999; 23(3):226-31. PubMed ID: 10337001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
    Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M
    Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.